Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Potamianos

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
BMC Gastroenterology|October 16, 2010
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndromeAnastassios C Manolakis, Andreas N Kapsoritakis, Panagiotis Georgoulias, et al.
Diabetologia|December 1, 2010
Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?A C Manolakis, E K Tiaka, A N Kapsoritakis, et al.
World Journal of Gastroenterology|July 19, 2008
Hemobilia as the initial manifestation of cholangiocarcinoma in a hemophilia B patientAnastassios-C Manolakis, Andreas-N Kapsoritakis, Antonis-D Tsikouras, et al.
Helicobacter|November 19, 2010
Impact of TLR-4 polymorphisms on circulating levels of antibodies against Helicobacter pyloriAnastassios C Manolakis, Andreas N Kapsoritakis, Elisavet K Tiaka, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 30, 2013
Lower fibroblast growth factor 23 levels in young adults with Crohn disease as a possible secondary compensatory effect on the disturbance of bone and mineral metabolismKonstantinos A Oikonomou, Timoklia I Orfanidou, Marianna K Vlychou, et al.
The American Journal of Gastroenterology|March 31, 2001
Mean platelet volume: a useful marker of inflammatory bowel disease activityA N Kapsoritakis, M I Koukourakis, A Sfiridaki, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2002
Diminutive polyps of large bowel should be an early target for endoscopic treatmentA N Kapsoritakis, S P Potamianos, M I Koukourakis, et al.
World Journal of Gastroenterology|February 18, 2017
α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel diseaseAnastassios C Manolakis, Gregory Christodoulidis, Andreas N Kapsoritakis, et al.
Growth Factors (Chur, Switzerland)|October 26, 2010
Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?Konstantinos A Oikonomou, Andreas N Kapsoritakis, Anastasia I Kapsoritaki, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2007
Prevalence of coeliac disease in the adult population of central GreeceVioleta Roka, Spyros P Potamianos, Andreas N Kapsoritakis, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
BMC Gastroenterology|October 16, 2010
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndromeAnastassios C Manolakis, Andreas N Kapsoritakis, Panagiotis Georgoulias, et al.
Diabetologia|December 1, 2010
Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?A C Manolakis, E K Tiaka, A N Kapsoritakis, et al.
World Journal of Gastroenterology|July 19, 2008
Hemobilia as the initial manifestation of cholangiocarcinoma in a hemophilia B patientAnastassios-C Manolakis, Andreas-N Kapsoritakis, Antonis-D Tsikouras, et al.
Helicobacter|November 19, 2010
Impact of TLR-4 polymorphisms on circulating levels of antibodies against Helicobacter pyloriAnastassios C Manolakis, Andreas N Kapsoritakis, Elisavet K Tiaka, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 30, 2013
Lower fibroblast growth factor 23 levels in young adults with Crohn disease as a possible secondary compensatory effect on the disturbance of bone and mineral metabolismKonstantinos A Oikonomou, Timoklia I Orfanidou, Marianna K Vlychou, et al.
The American Journal of Gastroenterology|March 31, 2001
Mean platelet volume: a useful marker of inflammatory bowel disease activityA N Kapsoritakis, M I Koukourakis, A Sfiridaki, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2002
Diminutive polyps of large bowel should be an early target for endoscopic treatmentA N Kapsoritakis, S P Potamianos, M I Koukourakis, et al.
World Journal of Gastroenterology|February 18, 2017
α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel diseaseAnastassios C Manolakis, Gregory Christodoulidis, Andreas N Kapsoritakis, et al.
Growth Factors (Chur, Switzerland)|October 26, 2010
Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?Konstantinos A Oikonomou, Andreas N Kapsoritakis, Anastasia I Kapsoritaki, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2007
Prevalence of coeliac disease in the adult population of central GreeceVioleta Roka, Spyros P Potamianos, Andreas N Kapsoritakis, et al.
Pageof 4